XML 44 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2023
Stockholders' Equity Note [Abstract]  
Schedule of activity under the stock option plans
   2010 Plan   2017 Plan   Weighted
Average
Exercise Price
   Aggregate
Intrinsic
Value(1)
 
Outstanding as of December 31, 2021   218,500    224,500   $6.94   $468,425 
Grants       210,500   $7.73      
Terminations/forfeitures(2)   (11,000)   (32,500)  $7.34      
Exercises   (5,000)      $6.13      
Outstanding as of December 31, 2022   202,500    402,500   $7.19   $(661,310)
Grants       84,000   $5.22      
Terminations/forfeitures(2)       (63,000)  $7.19      
Exercises          $      
Outstanding as of March 31, 2023   202,500    423,500   $6.93   $(1,107,030)
Vested as of March 31, 2023   188,500    59,500   $6.45   $(318,895)
Vested and expected to vest as of March 31, 2023   202,500    423,500   $6.93   $(1,107,030)
Reserved for future grants       208,500           

 

Schedule of additional information about the stock option plans
   Number of Shares   Weighted
Average
Fair Value at
Grant Date
   Weighted
Average
Exercise
Price
 
Non-vested stock options as of January 1, 2023   307,000   $3.80   $7.71 
Non-vested stock options as of March 31, 2023   378,000   $3.63   $7.25 
Stock options granted during the three-month period ended March 31, 2023   84,000   $2.88   $5.22 
Stock options that vested during the three-month period ended March 31, 2023   10,000   $2.03   $4.00 
Stock options that were terminated or forfeited during the three-month period ended March 31, 2023   63,000   $3.27   $7.19 

 

Schedule of fair value stock option grant using black-scholes option pricing model with the weighted-average assumptions
  

During the Three-Month
Periods Ended March 31,

 
   2023   2022 
Risk-free interest rate(1)   3.54%   1.63%
Dividend yield(2)   0%   0%
Expected volatility(2)   55%   52%
Expected life(3)   6.5 years    6.5 years